Z-1462-2022 Class II Terminated

Recalled by NordicNeuroLab AS — Bergen

FDA device recall Z-1462-2022 was initiated by NordicNeuroLab AS on June 16, 2022 and is designated Class II. Reason for recall: When exporting merged results from the BOLD, DSC, and DCE modules of nordicBrainEx, where both the underlay and overlay originated from a multiframe dataset, the resulting output may have left/right s… The recall status is terminated (terminated September 4, 2024). Affected quantity: 243 units.

Recall Details

Product Type
Devices
Report Date
August 3, 2022
Initiation Date
June 16, 2022
Termination Date
September 4, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
243 units

Product Description

nordicBrainEX, software versions 2.21 through 2.3.10

Reason for Recall

When exporting merged results from the BOLD, DSC, and DCE modules of nordicBrainEx, where both the underlay and overlay originated from a multiframe dataset, the resulting output may have left/right sides flipped.

Distribution Pattern

US Nationwide distribution.

Code Information

UDI 07090042059015, software versions 2.21 through 2.3.10